Vascular Occlusion or Anesthesia Blanching? How to Tell

Blanching is the best-known sign of vascular occlusion, and for that very reason the most misread. Pale skin after an anesthetic block, after pressing with a finger or after an injection that caused vasospasm is not always ischemia. The reverse mistake also exists: blaming anesthesia for blanching that was the first sign of an occlusion. This page lays out criteria for telling the two apart, without replacing training or current guidelines.

There are no doses, dilutions or injection technique here. The general concept is in vascular occlusion and the skin phenomenon in skin blanching.

Why does skin turn pale without an occlusion?

Several common situations produce temporary local pallor.

• Anesthetic with a vasoconstrictor. The epinephrine combined with the anesthetic constricts vessels and lightens the skin. The effect tends to be more obvious with blocks and infiltrations, and it fades with time. See local anesthesia in HOF: overview.
• Mechanical pressure. A finger, a cannula or injected volume compressing the skin can produce blanching that returns once released.
• Vasospasm. Pain, cold or irritation of the vessel from the needle or product cause a transient contraction, with pallor and sometimes pain.
• Ice and topical anesthetic. Cold and some formulations lighten superficial skin. See topical anesthetics: composition and risks.
• Naturally fair skin or areas with little visible vascularity, which give a false impression of blanching.

What these have in common is that they tend to improve with time, follow a diffuse pattern and not come with disproportionate pain.

What characterizes ischemia?

Ischemia from vascular occlusion has its own logic.

• Territory of one artery: the affected area follows the course of the vessel, often far from the injection point.
• Persistence: the pallor does not return when pressure is released and does not improve in the expected time.
• Disproportionate pain: greater than expected for the procedure, sometimes burning.
• Slow or absent capillary refill.
• Local coldness compared with the neighboring skin.
• Evolution: after the pallor, a purple net-like color appears (livedo), then localized swelling and, within hours, darkening.

The difference is therefore more about behavior over time than appearance at a single moment. A single photo misleads; two assessments a few minutes apart tell you much more.

Bedside decision table

The capillary refill test in practice

The exam is simple and should be part of every session's routine:

1. Press the skin of the area gently until it blanches, then release.
2. Watch how long the color takes to return.
3. Compare with the neighboring skin and the opposite side.
4. Repeat after a few minutes to see the trend.

On darker skin, blanching is less visible, and the test can be done by using the color of the nail bed as a comparison reference or by giving more weight to temperature and pain. The page HOF on Black skin discusses the adaptations. Good lighting helps: see lighting in the HOF practice.

When the doubt continues

Consensus guidelines converge on one point: if the doubt persists, treat it as a vascular suspicion. In practical terms:

1. Stop injecting in the area.
2. Reassess at short intervals, comparing with the opposite side.
3. With hyaluronic acid, consider hyaluronidase according to current guidelines and your judgment.
4. Record times and findings.
5. Ask for a second opinion, in person or by phone, from an experienced colleague.
6. Do not discharge the patient without clear signs of normalization and a follow-up plan.

The reasoning is cost-benefit: treating benign pallor as a suspicion costs a few minutes and an enzyme; ignoring an occlusion costs skin and sometimes vision.

Where the differential is hardest

Some areas and situations combine anesthesia, vasoconstriction and vascular risk:

• Lips. Blocks and topical anesthetic lighten the vermilion. See vascular occlusion in the lip.
• Chin. The mental nerve block anesthetizes and blanches the area. See vascular occlusion in the chin.
• Forehead and glabella. Supraorbital and supratrochlear blocks lighten the skin. See vascular occlusion in the forehead and glabellar vascular occlusion.
• Nasolabial fold and nose. Territory of branches of the facial and angular arteries. See vascular occlusion in the nasolabial fold and nasal vascular occlusion.
• Temples. Hair makes the reading harder. See vascular occlusion in the temples.

In every case, the rule is the same: watch the evolution, compare both sides, give weight to disproportionate pain and have a protocol.

Setting up the observation routine

How to talk to the patient when you are in doubt

It is worth being transparent without alarming. Patients notice the professional's silence.

In Harmy

Summary

Benign pallor improves and is diffuse; ischemia persists, follows a territory, hurts more than it should, turns cold and evolves into a purple net pattern. Capillary refill, comparison between sides and observation over time are the tools. When doubt remains, treat it as a vascular suspicion. See also the general review in safety and complications and the setup in hyaluronidase in the practice.